Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 110(24): 9998-10003, 2013 Jun 11.
Article in English | MEDLINE | ID: mdl-23716689

ABSTRACT

Urinary ammonium excretion by the kidney is essential for renal excretion of sufficient amounts of protons and to maintain stable blood pH. Ammonium secretion by the collecting duct epithelia accounts for the majority of urinary ammonium; it is driven by an interstitium-to-lumen NH3 gradient due to the accumulation of ammonium in the medullary and papillary interstitium. Here, we demonstrate that sulfatides, highly charged anionic glycosphingolipids, are important for maintaining high papillary ammonium concentration and increased urinary acid elimination during metabolic acidosis. We disrupted sulfatide synthesis by a genetic approach along the entire renal tubule. Renal sulfatide-deficient mice had lower urinary pH accompanied by lower ammonium excretion. Upon acid diet, they showed impaired ammonuria, decreased ammonium accumulation in the papilla, and chronic hyperchloremic metabolic acidosis. Expression levels of ammoniagenic enzymes and Na(+)-K(+)/NH4(+)-2Cl(-) cotransporter 2 were higher, and transepithelial NH3 transport, examined by in vitro microperfusion of cortical and outer medullary collecting ducts, was unaffected in mutant mice. We therefore suggest that sulfatides act as counterions for interstitial ammonium facilitating its retention in the papilla. This study points to a seminal role of sulfatides in renal ammonium handling, urinary acidification, and acid-base homeostasis.


Subject(s)
Acidosis/metabolism , Ammonia/metabolism , Kidney/metabolism , Sulfoglycosphingolipids/metabolism , Acidosis/pathology , Acidosis/urine , Ammonia/urine , Animals , Blotting, Western , Female , Glucosyltransferases/deficiency , Glucosyltransferases/genetics , Homeostasis , Hydrogen-Ion Concentration , Kidney Tubules/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Sulfotransferases/deficiency , Sulfotransferases/genetics , Symporters/genetics , Symporters/metabolism , Urine/chemistry
2.
Am J Pathol ; 175(5): 1883-95, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19834063

ABSTRACT

The role of vascular endothelial growth factor (VEGF) in renal fibrosis, tubular cyst formation, and glomerular diseases is incompletely understood. We studied a new conditional transgenic mouse system [Pax8-rtTA/(tetO)(7)VEGF], which allows increased tubular VEGF production in adult mice. The following pathology was observed. The interstitial changes consisted of a ubiquitous proliferation of peritubular capillaries and fibroblasts, followed by deposition of matrix leading to a unique kind of fibrosis, ie, healthy tubules amid a capillary-rich dense fibrotic tissue. In tubular segments with high expression of VEGF, cysts developed that were surrounded by a dense network of peritubular capillaries. The glomerular effects consisted of a proliferative enlargement of glomerular capillaries, followed by mesangial proliferation. This resulted in enlarged glomeruli with loss of the characteristic lobular structure. Capillaries became randomly embedded into mesangial nodules, losing their filtration surface. Serum VEGF levels were increased, whereas endogenous VEGF production by podocytes was down-regulated. Taken together, this study shows that systemic VEGF interferes with the intraglomerular cross-talk between podocytes and the endocapillary compartment. It suppresses VEGF secretion by podocytes but cannot compensate for the deficit. VEGF from podocytes induces a directional effect, attracting the capillaries to the lobular surface, a relevant mechanism to optimize filtration surface. Systemic VEGF lacks this effect, leading to severe deterioration in glomerular architecture, similar to that seen in diabetic nephropathy.


Subject(s)
Cysts , Glomerulonephritis , Kidney Diseases , Kidney Glomerulus , Kidney Tubules , Vascular Endothelial Growth Factor A/metabolism , Animals , Capillaries/cytology , Capillaries/metabolism , Capillaries/pathology , Cysts/metabolism , Cysts/pathology , Fibrosis/metabolism , Fibrosis/pathology , Glomerulonephritis/metabolism , Glomerulonephritis/pathology , Humans , In Situ Hybridization , Kidney Diseases/metabolism , Kidney Diseases/pathology , Kidney Glomerulus/cytology , Kidney Glomerulus/metabolism , Kidney Glomerulus/pathology , Kidney Tubules/cytology , Kidney Tubules/metabolism , Kidney Tubules/pathology , Mice , Mice, Transgenic , Podocytes/cytology , Podocytes/metabolism , Podocytes/pathology
3.
Nat Med ; 14(9): 979-84, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18724376

ABSTRACT

We describe a transgenic mouse line, Pax8-rtTA, which, under control of the mouse Pax8 promoter, directs high levels of expression of the reverse tetracycline-dependent transactivator (rtTA) to all proximal and distal tubules and the entire collecting duct system of both embryonic and adult kidneys. Using crosses of Pax8-rtTA mice with tetracycline-responsive c-MYC mice, we established a new, inducible model of polycystic kidney disease that can mimic adult onset and that shows progression to renal malignant disease. When targeting the expression of transforming growth factor beta-1 to the kidney, we avoided early lethality by discontinuous treatment and successfully established an inducible model of renal fibrosis. Finally, a conditional knockout of the gene encoding tuberous sclerosis complex-1 was achieved, which resulted in the early outgrowth of giant polycystic kidneys reminiscent of autosomal recessive polycystic kidney disease. These experiments establish Pax8-rtTA mice as a powerful tool for modeling renal diseases in transgenic mice.


Subject(s)
Disease Models, Animal , Kidney Tubules/physiology , Polycystic Kidney Diseases/genetics , Trans-Activators/genetics , Animals , Doxycycline/blood , Doxycycline/metabolism , Doxycycline/pharmacology , Fibrosis/genetics , Fibrosis/physiopathology , Immunohistochemistry , Kidney Tubules/metabolism , Kidney Tubules/pathology , Mice , Mice, Transgenic , PAX8 Transcription Factor , Paired Box Transcription Factors/genetics , Polycystic Kidney Diseases/physiopathology , Promoter Regions, Genetic/genetics , Trans-Activators/metabolism , Transforming Growth Factor beta1/metabolism , Tuberous Sclerosis Complex 1 Protein , Tumor Suppressor Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL